Figures at $766.30 BNB, the Oct 2, 2026 close. All amounts in US dollars.
The illusion of gross holdings
Nano Labs NA
At 0.90x gross mNAV Nano Labs looks like it trades below its BNB. But $31.8M of bank and USDT loans, net of $10.1M of cash, match 40% of its 70,000 BNB reserve. Priced on the whole balance sheet it trades at 1.30x EV, and 1.68x leverage lifts that to 1.50x CEBE mNAV. Equity NAV reaches zero near $309 BNB. The reserve is also shrinking: the company held 103,357 BNB at June 30.
A discount on a clean balance sheet
BNB Standard BNC
The former CEA Industries holds the largest corporate treasury, 515,544 BNB. Its $16.8M of debt is more than half covered by cash and stablecoins, so net claims match just 2% of the treasury. At 0.80x EV and 0.79x CEBE mNAV, $1,000 of stock carries 1.65 BNB of equity, against 1.30 BNB if you bought BNB outright. The cost that isn't on the balance sheet is its asset manager's 1.4% annual fee, about $5.5M or 7,200 BNB a year, which the company is fighting in court.
A treasury in retreat
BNB Plus BNBX
The former Applied DNA Sciences holds about 18,600 BNB, counting BNB lent out under call options and inside Osprey trust units. Nasdaq delisted it in July, and on October 2 it said it will move away from a pure treasury model. Its whole equity, common plus convertible preferred, trades at about 0.13x gross mNAV, but the preferred can be redeemed for cash on events that include a delisting, so it stays out of the matrix.
Announced, never funded
Liminatus LIMN & Windtree WINT
Both announced BNB treasuries in July 2025, Liminatus of up to $500M. Liminatus's June 30, 2026 10-Q reports no digital assets, and it has since done a 1-for-50 reverse split to keep its Nasdaq listing. Windtree was delisted from Nasdaq on Aug 21, 2025 and hasn't filed its 2025 annual report. Headline commitments are not holdings.